Posted by Michael Wonder on 30 Jul 2020
FDA nears decision authorising COVID-19 treatment with convalescent plasma
29 July 2020 - Antibody-rich blood plasma would be one of the first coronavirus treatments to receive approval, which could pave way for wider use.
The Food and Drug Administration is nearing a decision to authorise emergency use of antibody-rich blood plasma from recovered COVID-19 patients for treating those infected with the coronavirus, people familiar with the matter said.
The authorisation could come as soon as next week, according to the people, though the agency could also decide to delay a decision.
